Dublin, Jan. 26, 2016 -- Research and Markets (http://www.researchandmarkets.com/research/n8vbnd/lyophilized) has announced the addition of the "Lyophilized Injectables to 2020" report to their offering.
The inherent instability of protein drugs is a limitation that has a direct impact on the drug delivery sector. Therapeutic proteins must either be stored under special conditions or formulated to retain their efficacy from the time of manufacture until they are dispensed. Liquid protein drugs require refrigeration until dispensed - a requirement referred to as the cold chain'. Alternatively, proteins can be formulated as powders (lyophilization). Lyophilized proteins must be reconstituted prior to injection. Lyophilized drugs are sold with reconstitution vial systems, or packaged in special injection devices (e.g., pens, needle-free injectors, two-part syringes) that allow reconstitution to take place in the device prior to injection.
What You Will Learn
- Provides detailed analysis of lyophilized drugs, as-supplied packaging and therapeutic indication
- Analyzes therapeutic demand drivers and evaluates lyophilized drugs in eleven therapeutic areas
- Analyzes lyophilization technologies and market development issues
- Provides market data and forecasts to 2020
- Profiles market participants, their product development activities, business strategies, and corporate alliances and affiliations
- Assesses the importance of technology and regulatory factors on commercialization and market access
Key Topics Covered:
1. Executive Summary
2. The Market Opportunity
- Delivery Market Dynamics
- The Economics of lyophilized Drugs
- What's Driving the Market for Lyophilized Drugs?
- The Trend toward Self-Administration
- Shifting Demographics
- Innovation in Disposable Device Designs
- Therapeutic Demand Drivers
- Competitive Landscape
- Risk Factors
3. Lyophilized Drugs - Primary Packaging
- Single Use Vials
- Point-of-Care Reconstitution
- Specialty Packaging
- Drugs for SC/IM Injection
- Drugs for Infusion
- Product Specific Devices
4. Lyophilized Drugs - Reconstitution and Delivery
- Prefilled Diluent Syringes
- Proprietary Reconstitution Devices
- Single Step Devices
- Multi-Step Devices
- Human Engineering/Ergonomics
5. Lyophilized Drugs - Key Therapeutic Sector Analysis and Market Data
- Antibiotics
- Autoimmune Diseases
- Blood Factors
- Hormones
- Infectious Diseases
- Metabolic Conditions
- Oncology
- Reproductive Health
- Other Important Therapeutic Classes
6. Market Factors
- Regulatory Issues
- Patient Compliance and Ease of Use
- Healthcare Economics
7. Company Profiles
For more information visit http://www.researchandmarkets.com/research/n8vbnd/lyophilized
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716


Google Gemini Co-Lead Noam Shazeer Leaves for OpenAI Amid AI Talent Race
JPMorgan Sees Strong Strategic Value in Potential AbbVie Acquisition of Apogee Therapeutics
TD Bank Expands Employee Monitoring Software to Boost Productivity Amid Privacy Concerns
US-Iran De-Escalation Shifts Washington’s Focus to AI Regulation and Crypto Legislation
Kingboard Holdings Shares Surge After HK$11.77 Billion Block Trade to Expand PCB and AI Supply Chain Business
Carro Expands Into Australia With Acquisition of Used-Car Platform CarPlace
Apple Signals Product Price Hikes Amid Rising Memory Chip Costs
Samsung Gains Interest from BYD, Google, AMD as AI Chip Demand Strains TSMC Capacity
J.P. Morgan Sees Potential Vestas Guidance Upgrade Amid Strong Wind Energy Demand
Chinese Social Media Giant Xiaohongshu Eyes Hong Kong IPO at Over $70 Billion Valuation
Hyundai to Acquire SoftBank’s Remaining Boston Dynamics Stake for $325 Million
Google’s Open-Source AI Data Center Cooling Design Raises Commoditization Concerns
GM and Lockheed Martin Partner to Strengthen U.S. Defense Manufacturing Capacity
SK Hynix Shares Hit Record High After Shipping Next-Generation HBM4E AI Memory Samples
China Adds MP Materials, USA Rare Earth to Export Control List Amid Escalating U.S.-China Trade Tensions
Meta Seeks Legal Shield From Child-Harm Lawsuits Amid KOSA Talks
SpaceX Stock Slides After IPO Rally as Valuation Concerns Grow 



